REQSX
Price
$21.23
Change
-$0.05 (-0.23%)
Updated
Apr 25 closing price
Net Assets
154.29M
VIVAX
Price
$64.30
Change
-$0.11 (-0.17%)
Updated
Apr 25 closing price
Net Assets
190.51B
Ad is loading...

REQSX vs VIVAX

Header iconREQSX vs VIVAX Comparison
Open Charts REQSX vs VIVAXBanner chart's image
Russell Inv Equity Income C
Price$21.23
Change-$0.05 (-0.23%)
VolumeN/A
Net Assets154.29M
Vanguard Value Index I
Price$64.30
Change-$0.11 (-0.17%)
VolumeN/A
Net Assets190.51B
REQSX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REQSX vs. VIVAX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REQSX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. REQSX (154M). VIVAX pays higher dividends than REQSX: VIVAX (2.14) vs REQSX (0.96). REQSX was incepted earlier than VIVAX: REQSX (17 years) vs VIVAX (33 years). REQSX (1.95) is less costly to investors than VIVAX (0.17). REQSX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (10.00). REQSX has a lower initial minimum investment than VIVAX: REQSX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 4.60 vs. REQSX (-9.00). VIVAX return over 5 years is better than : 71.57 vs. REQSX (6.26).
REQSXVIVAXREQSX / VIVAX
Total Expense Ratio1.870.171,100%
Annual Report Gross Expense Ratio1.950.171,147%
Fund Existence17 years33 years-
Gain YTD-1.801-2.47273%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets154M191B0%
Annual Yield % from dividends0.962.1445%
Returns for 1 year-9.004.60-196%
Returns for 3 years-23.1915.85-146%
Returns for 5 years6.2671.579%
Returns for 10 years-43.7293.13-47%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBIO2.780.20
+7.75%
Orchestra BioMed Holdings
CTEV22.990.42
+1.86%
Claritev Corporation
SLRX0.730.01
+1.84%
Salarius Pharmaceuticals Inc.
JBI6.860.10
+1.48%
Janus International Group
SGI60.73-0.86
-1.40%
Somnigroup International Inc.